Clinical Trial

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers
Protocol Amendment History 3 changes
critical Completed without a posted recruiting period 2026-07-29
notable Primary completion pushed: 2026-01 -> 2026-03-07 2026-07-29
minor Completion pushed: 2026-01 -> 2026-03-07 2026-07-29
Trial Details
NCT Number NCT07103278
Lead Sponsor Addpharma Inc.
Conditions Benign Prostatic Hyperplasia
Enrollment 44 participants
Start Date 2026-01-22
Primary Completion 2026-03-07 (estimated)
Study Completion 2026-03-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-28